Monash establishes Australian-first ‘Monash Boston Hub’ to advance drug discovery and health innovations; Australia has a strong track record in translating drug discoveries into candidates ready for ...
Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) are among the team supporting the newly established Australian Venom Innovation and Discovery (AVID) Initiative.
The largest study of its kind has found menopause is not associated with an increased risk of disability in women with multiple sclerosis (MS). Until now, the impact of reduced sex hormones on women ...
Professor Jennifer Hill is the Inaugural Bob Baxt AO Chair of Corporate and Commercial Law and Director of CLARS. Her scholarship on comparative corporate law and governance is widely cited in ...
In a major advance for infectious disease treatment, researchers from Monash University and The Alfred have developed a bespoke phage therapy product that uses bacterial viruses, known as ...
The registry is a contact list of individuals with cerebellar ataxia who are willing to be contacted for participation in research studies and clinical trials. When signing up, you will fill out some ...
Your study options Part-time study Part-time study Mature age learning Mature age learning ...
Please note, conditional offers are not issued for this course and we do not consider incomplete, predicted, or provisional results. Offers will only be released once applicants have provided: ...
For 2026, the faculty has a limited number of Commonwealth Supported Places (CSP) in A6007 Master of Interpreting and Translation Studies for Australian domestic applicants. CSPs are awarded to ...
Monash University is set to grow its Indonesia campus with the introduction of bachelor programs in 2026. Since the inaugural ...
The inaugural Fellowship program is set to be announced at the official launch of the Constructive Institute Asia Pacific Hub, where Director Kate Torney will lead a panel of experts to discuss the ...
Monash invention progresses to Phase 3 clinical trial for treatment of advanced breast cancers ; Monash invention progresses to Phase 3 clinic ...